Category - FSE

Breaking News Cannabinoids Cannabis Buzz CannabisExtraction CannabisOil CapitalInvestment Distillation EBITDA financialresults FSE Latest Market News Medical Use MediPharmLabs OTCQX revenue strategy The Market Buzz TSX

Breaking News: MediPharm Labs Announces Q1 2019 Revenue of $ 22 Million and Adjusted EBITDA of $ 4.3 Million

MediPharm Labs Corp. (TSX-V: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or “Company”) a worldwide leader in specialized research-driven hashish...

BlockstrainTechnology Breaking News Cannabis Buzz CannabisOil Distribution FSE JointVenture JonasVanderzwan JosephineDesLAuriers KeithMerker KevinMcGovern Latest Market News Medical Use MedicalCannabis MedicalPatients MichaelPesner NicholaThompson OTCQX Phivida Producer The Market Buzz TruTrace TSX WeedMD

News: WeedMD Reports Financial Year 2018 Financial Results

WeedMD Inc. (TSX-V: WMD) (OTCQX: WDDMF) (FSE: 4WE) ("WeedMD" or "Company"), a producer and distributor of medical cannabis, is pleased to...

Beverages Breaking News Cannabinoids Cannabis Buzz CannabisDistillation CannabisExtraction Cultivation EBITDA Edibles EmeraldHealthTherapeutics financialresults FinancialStatements FSE JamesWagner Latest Market News MediPharmLabs OTCQB PatrickCutcheon Purification Research strategy The Market Buzz Topicals TSX Vapes

News: MediPharm Labs reports Q4 2018 Revenue $ 10.2 million and adjusted EBITDA $ 2.1 million

MediPharm Labs Corp. (TSX-V: LABS) (OTCQB: MLCPF) (FSE: MLZ) ("MediPharm Labs" or "Company"), a worldwide chief in specialised, research...